AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

In-hospital Stellate Ganglion Block for Arrhythmic Storm

Recruitingn/aAges any - anyAllFondazione IRCCS Policlinico San Matteo di Pavia
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Arrhythmic storm is a real emergency and its treatment could be challenging. Antiarrhythmic drugs are few and often ineffective. Neuromodulation has been grown in evidences but no large multicentric studies are present in literature about safety and effectiveness of Percutaneous Stellate Ganglion Block (PSGB). Patients with an electrical storm refractory to at least one antiarrhythmic drug will receive PSGB and will be enrolled in the present study. The number of defibrillations before and after the treatment will be compared, complications will be annotated.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * age โ‰ฅ 18 years, * presence of arrhythmic storm defined as more than three sustained ventricular arrhythmias in 24 hours refractory to the standard medical treatment. Exclusion Criteria: * A previous history of cardiac sympathicectomy * Having a neck judged unsuitable for the procedure (previous neck surgery, previous burns, presence of large scars, thyroid goiter) Both the two approaches present in literature and commonly used for this technique are allowed for the study: * The "anatomical" approach which consist in the identification of the Chassaignac's tubercle that represents the point of needle insertion * The "echo-guided" approach Regardless to the approach (anatomical or echo-guided) the doctor will be able to choose, according to the clinical characteristics of the patients, whether to perform a single shot injection of anesthetic or a continuous infusion of anesthetic. In the second case a catheter will be left in place and connected to an infusion pump.
๐Ÿ’Š

What it tests

  • Percutaneous stellate ganglion block (PSGB)
๐Ÿ“

Where

38 sites
A.O. SS. Antonio e Biagio e Cesare Arrigo di Alessandria.
Alessandria, Italy
Ospedale di Bentivoglio
Bentivoglio, Italy
Ospedale Maggiore di Bologna
Bologna, Italy
Cardiology Department, Fondazione IRCCS Policlinico San Matteo
Pavia, Italy
Ospedale Civile
Voghera, Italy
Ospedale Mater Salutis
Legnago, Italy
A.O.U. delle Marche, Ospedali Riuniti
Ancona, Italy
Ospedale Cardinal Massaia
Asti, Italy

โ€ฆand 30 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy